Rapamycin (Sirolimus) | ≥99%(HPLC) | Selleck
Rapamycin also known as Sirolimus & Rapamune is an mTOR inhibitor. Rapamycin Sirolimus inhibits cell motility by suppression of mTOR-mediated pathways. Find all the information about Rapamycin (Sirolimus) for cell signaling research.
Rapamycin extends lifespan in mice. In their important 2009 paper, the NIA’s intervention testing program (ITP) identified rapamycin as the first pharmacological agent to extend maximal lifespan in a mammalian species, with effects in both males and females [] (Table 1).Rapamycin was encapsulated (to increase bioavailablity of the drug) and delivered via the mouse chow at a concentration of
Rapamycin | mTOR Inhibitors | Buy Sirolimus from Supplier
Rapamycin (Sirolimus) Chemical Structure CAS NO. 53123-88-9 Rapamycin (Sirolimus) prevents activation of T cells and B-cells by inhibiting their response to interleukin-2 (IL-2).
Rapamycin is a chemical produced by soil bacteria. In lab experiments, the chemical has significantly lengthened the lifespan of yeasts, worms, fruit flies, and mice. It's currently being tested in pet dogs. If this trial is successful, rapamycin may then be tested in humans. Rapamycin seems to work by inhibiting a protein known as mTOR.
Trade Assurance protects your orders
Trade Assurance protects the buyer in the event that the supplier fails to ship on time or the product quality varies from what has been agreed upon. While charges transaction fees on certain payment methods to offset our operational expense in payment processing, we do not charge any additional fees for Trade Assurance.
Rapamycin is the best anti-aging treatment yet discovered. Most treatments that work in flies and worms fail when they get to mammals, but rapamycin has consistently extended lifespan more than 20% in mice [review as or 2014].. It works even when administered late in life, and intermittent dosing works as well or sometimes better than daily dosing.
Kazia Therapeutics : Half Year Accounts and Chairman's
Kazia Therapeutics Limited Directors' report 31 December 2025 The directors present their report, together with the financial statements, on the consolidated entity (referred to hereafter as the 'consolidated entity') consisting of Kazia Therapeutics Limited (referred to hereafter as the 'company' or 'parent entity') and the entities it controlled at the end of, or during, the half-year ended
Form 20-F ASTRAZENECA PLC For: Dec 31 Trade and other receivables decreased by $2,055 million in 2016 with Sweden and Germany arising from reductions in discount rate assumptions were
Anti-von Willebrand Factor Antibody | AB7356
Anti-von Willebrand Factor Antibody Anti-von Willebrand Factor, Cat. No. AB7356, is a rabbit polyclonal antibody that detects von Willebrand Factor and has been tested for use in ELISA, Immunohistochemistry, and Western Blotting. - Find MSDS or SDS, a COA, data sheets and more information.
Business Analyst, BS degree with 3+ years of experience: communicate with the Information Technology group and business regarding IT projects and new initiatives by Documenting business requirements and participating in stake-holder meetings Analyzing CPG retail (Consumer Packaged Goods) business trends.
Amendment No. 4 to Form S-1 - SEC.gov | HOME
We have also entered into a collaboration with Ares Trading S.A., a subsidiary of Merck KGaA, Darmstadt, Germany, or Merck KGaA, and Pfizer Inc. to evaluate the safety, tolerability and preliminary efficacy of entinostat in combination with an investigational monoclonal antibody targeting PDL-1, avelumab, in a Phase 1b/2 clinical trial, ENCORE
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
- What factors affect the flocculation effect of cationic polyacrylamide (CPAM)?
- Cationic polyacrylamide (CPAM) is a commonly used flocculant for water treatment. Factors that affect the flocculation effect and can be controlled manually include the type and dosage of CPAM, wastewater pH, stirring time and settling time, and their reasonable setting is critical to the flocculation effect of CPAM.
- What is high molecular weight polyacrylamide (PAM)?
- Provided by the Springer Nature SharedIt content-sharing initiative High molecular weight (106–3 × 107 Da) polyacrylamide (PAM) is commonly used as a flocculant in water and wastewater treatment, as a soil conditioner, and as a viscosity modifier and friction reducer in both enhanced oil recovery and high volume hydraulic fracturing.
- What is cationic polyacrylamide (CPAM)?
- Cationic polyacrylamide (CPAM) is one of the most frequently used flocculants with high intrinsic viscosity and charge density. This flocculant is a water-soluble acrylamide-based polymer having cationic quaternary ammonium groups .
- Are cationic polyacrylamide copolymers bad for the environment?
- Cationic polyacrylamide copolymers (PAMs) are used for sludge dewatering in municipal waste water treatment and might enter the environment by spreading of the sludge on agricultural land. Concern has been expressed since little is known about the degradation of PAMs in soils.
